Stocks
Globe Life Financial Statements (GL) |
||||||||||
| Globe Lifesmart-lab.ru | % | 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 25.02.2021 | 24.02.2022 | 23.02.2023 | 31.12.2023 | 28.02.2024 | 31.03.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 4 738 | 5 113 | 5 215 | 5 448 | 5 448 | 5 632 | |||
| Operating Income, bln rub | 895.4 | 911.2 | 996.7 | 4 720 | 1 297 | 3 115 | ||||
| EBITDA, bln rub | ? | 895.4 | 911.2 | 996.7 | 0.000 | -103.2 | 263.6 | |||
| Net profit, bln rub | ? | 731.8 | 745.0 | 894.4 | 970.8 | 970.8 | 1 061 | |||
| OCF, bln rub | ? | 1 476 | 1 438 | 1 422 | 0.000 | 1 482 | 678.3 | |||
| CAPEX, bln rub | ? | 41.8 | 38.2 | 27.9 | 0.000 | 49.6 | 23.9 | |||
| FCF, bln rub | ? | 1 435 | 1 399 | 1 394 | 0.000 | 1 433 | 654.4 | |||
| Dividend payout, bln rub | 78.2 | 80.0 | 80.5 | 0.000 | 84.1 | 42.5 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 10.7% | 10.7% | 9.01% | 0.00% | 8.67% | 4.01% | ||||
| OPEX, bln rub | 3 843 | 4 202 | 3 864 | 727.5 | 707.1 | 2 517 | ||||
| Cost of production, bln rub | 301.0 | 322.0 | 354.0 | 0.000 | 347.8 | 85.9 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 86.7 | 83.5 | 90.4 | 102.3 | 102.3 | 77.3 | ||||
| Assets, bln rub | 29 047 | 29 768 | 25 537 | 0.000 | 28 051 | 0.000 | ||||
| Net Assets, bln rub | ? | 8 771 | 8 643 | 4 896 | 0.000 | 4 487 | 4 487 | |||
| Debt, bln rub | 1 923 | 2 026 | 2 077 | 0.000 | 2 116 | 0.000 | ||||
| Cash, bln rub | 21 416 | 21 467 | 16 710 | 0.000 | 18 055 | 0.000 | ||||
| Net debt, bln rub | -19 493 | -19 440 | -14 633 | 0.00 | -15 939 | 0 | ||||
| Ordinary share price, rub | 95.0 | 93.7 | 120.6 | 121.7 | 121.7 | 115.9 | ||||
| Number of ordinary shares, mln | 106.1 | 102.1 | 97.9 | 96.4 | 95.1 | 95.2 | ||||
| Market cap, bln rub | 10 073 | 9 566 | 11 805 | 11 729 | 11 575 | 11 030 | ||||
| EV, bln rub | ? | -9 420 | -9 874 | -2 828 | 11 729 | -4 364 | 11 030 | |||
| Book value, bln rub | 7 888 | 7 679 | 3 932 | 0 | -2 004 | 4 487 | ||||
| EPS, rub | ? | 6.90 | 7.30 | 9.13 | 10.1 | 10.2 | 11.1 | |||
| FCF/share, rub | 13.5 | 13.7 | 14.2 | 0.00 | 15.1 | 6.87 | ||||
| BV/share, rub | 74.4 | 75.2 | 40.2 | 0.00 | -21.1 | 47.1 | ||||
| EBITDA margin, % | ? | 18.9% | 17.8% | 19.1% | 0.00% | -1.89% | 4.68% | |||
| Net margin, % | ? | 15.4% | 14.6% | 17.2% | 17.8% | 17.8% | 18.8% | |||
| FCF yield, % | ? | 14.2% | 14.6% | 11.8% | 0.00% | 12.4% | 5.93% | |||
| ROE, % | ? | 8.34% | 8.62% | 18.3% | 21.6% | 23.6% | ||||
| ROA, % | ? | 2.52% | 2.50% | 3.50% | 3.46% | |||||
| P/E | ? | 13.8 | 12.8 | 13.2 | 12.1 | 11.9 | 10.4 | |||
| P/FCF | 7.02 | 6.84 | 8.47 | 8.08 | 16.9 | |||||
| P/S | ? | 2.13 | 1.87 | 2.26 | 2.15 | 2.12 | 1.96 | |||
| P/BV | ? | 1.28 | 1.25 | 3.00 | -5.77 | 2.46 | ||||
| EV/EBITDA | ? | -10.5 | -10.8 | -2.84 | 42.3 | 41.9 | ||||
| Debt/EBITDA | -21.8 | -21.3 | -14.7 | 154.4 | 0 | |||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| CAPEX/Revenue, % | 0.88% | 0.75% | 0.54% | 0.00% | 0.91% | 0.42% | ||||
| Globe Life shareholders | ||||||||||
